Amy Sanghavi (Sanghavi) Shah MD MD MS FNLA (She/Her)
Pediatric Diabetes Endocrinology, Pediatric Obesity
Division Director, Pediatric Endocrinology. Professor, Pediatrics, Cincinnati Children's Hospital Medical Center & The University of Cincinnati College of Medicine
Join to view full profile
3333 Burnet Ave# ML5012Cincinnati, OH 45229
Phone+1 513-636-4744
Dr. Shah is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amy (Sanghavi) Shah is a pediatric endocrinologist in Cincinnati, OH, specializing in pediatric diabetes endocrinology and pediatric obesity. She completed her pediatrics residency at Loyola University Medical Center and a fellowship in pediatric endocrinology at Cincinnati Children's Hospital Medical Center, followed by a Master's in Clinical and Translational Research from the University of Cincinnati. She has served as a professor at Cincinnati Children's Hospital Medical Center and has extensive experience in lipid metabolism disorders, type 2 diabetes mellitus, and early cardiovascular disease risk factors. Her research is reflected in several publications on youth-onset type 2 diabetes and metabolic syndromes. Dr. Shah has been recognized with awards such as an Endowed Scholar from Cincinnati Children's Research Foundation and has served as a principal investigator in clinical trials.
Education & Training
University of CincinnatiMS, Clinical and Translational Research, 2009 - 2011
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Endocrinology, 2007 - 2010
Loyola University Medical CenterResidency, Pediatrics, 2004 - 2007
St. George's University School of MedicineClass of 2004
Certifications & Licensure
OH State Medical License 2007 - 2028
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
National Lipid AssociationBoard Certified in Clinical Lipidology
Awards, Honors, & Recognition
- Endowed Scholar Cincinnati Children’s Research Foundation, 2022
- Fellow Fellow, National Lipid Association, 2020
- Young Investigator Award The National Lipid Association, 2016
Clinical Trials
- Surgical or Medical Treatment Start of enrollment: 2019 Dec 15
Roles: Contact, Principal Investigator
- Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia Start of enrollment: 2021 Jan 27
Roles: Principal Investigator
Publications & Presentations
PubMed
- Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in an adolescent with type 2 diabetes.Natalie Segev, Ryan P Brady, Lawrence Dolan, Amy S Shah
JCEM Case Reports. 2026-12-01 - Beware the song of the Sirens: why prevention still matters in the era of GLP-1 therapy.Robert M Siegel, Tina L Cheng, Amy S Shah
Pediatric Research. 2026-11-05 - Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis.Yllka Valdez, Natalie Segev, Neha Parimi, Manasi Vegesna, Elizabeth A Brown
Journal of Pediatric Endocrinology & Metabolism. 2026-10-26
Press Mentions
What’s Driving the Rise of GLP-1 Utilization in Children?April 30th, 2025
USPSTF Recommends Behavioral Interventions for Kids with High BMIJune 18th, 2024
Weight Loss Surgery May Boost Good Cholesterol in Obese BoysMay 5th, 2016
Grant Support
- Cincinnati Children's Clinical Center for Targeting the Pathophysiology of Youth-Onset Type 2 DiabetesCINCINNATI CHILDRENS HOSP MED CTR2023–2029
- Understanding the Impact of Youth Onset Obesity and Type 2 Diabetes on the Neurovascular UnitCINCINNATI CHILDRENS HOSP MED CTR2022–2027
- Role of apoE in HDL-mediated enhanced survival of human regulatory T-cellsCINCINNATI CHILDRENS HOSP MED CTR2023–2026
- Lipoprotein Interactions in the Vessel WallCINCINNATI CHILDRENS HOSP MED CTR2021–2025
- Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)CINCINNATI CHILDRENS HOSP MED CTR2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: